Syon Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.17M Buy
32,155
+2,817
+10% +$657K 0.36% 51
2026
Q1
$7.17M Buy
29,338
+127
+0.4% +$29.6K 0.36% 45
2025
Q4
$6.05M Buy
29,211
+1,914
+7% +$378K 0.3% 52
2025
Q3
$5.06M Buy
27,297
+894
+3% +$153K 0.27% 57
2025
Q2
$4.03M Sell
26,403
-3,038
-10% -$467K 0.27% 61
2025
Q1
$4.88M Buy
29,441
+3,444
+13% +$539K 0.4% 51
2024
Q4
$3.76M Sell
25,997
-226
-0.9% -$35K 0.34% 56
2024
Q3
$4.25M Sell
26,223
-5,233
-17% -$834K 0.38% 53
2024
Q2
$4.6M Buy
31,456
+814
+3% +$121K 0.42% 45
2024
Q1
$4.85M Buy
30,642
+3,601
+13% +$573K 0.46% 41
2023
Q4
$4.24M Buy
27,041
+8,292
+44% +$1.27M 0.43% 43
2023
Q3
$2.92M Buy
+18,749
New +$3.09M 0.36% 49

Other funds holding JNJ

Syon Capital's JNJ Position: Q2 2026 in Review

Syon Capital increased its Johnson & Johnson (JNJ) stake by 9.6% in Q2 2026, buying an estimated $657K and bringing the position to 32,155 shares worth $8.17M. The position accounts for 0.36% of the portfolio, ranked #51.

Syon Capital first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Syon Capital held 32,155 shares of Johnson & Johnson worth $8.17M as of Q2 2026.
  • Syon Capital bought 2,817 Johnson & Johnson shares in Q2 2026, an estimated $657K.
  • Johnson & Johnson made up 0.36% of Syon Capital's portfolio in Q2 2026, its #51 holding.
  • Syon Capital first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.